Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Malignant Melanoma.

Trial Profile

Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Malignant Melanoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2009

At a glance

  • Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2009 Planned number of patients changed from 20 to 40 as reported by ClinicalTrials.gov.
    • 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Apr 2008 Status change from recruiting to in progress, according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top